126 related articles for article (PubMed ID: 38153980)
21. Causes of Uveitis in a Tertiary Center in Chile: A Cross-sectional Retrospective Review.
Liberman P; Gauro F; Berger O; Urzua CA
Ocul Immunol Inflamm; 2015 Aug; 23(4):339-345. PubMed ID: 25437569
[TBL] [Abstract][Full Text] [Related]
22. Patterns of uveitis in a tertiary eye care center in Iran.
Soheilian M; Heidari K; Yazdani S; Shahsavari M; Ahmadieh H; Dehghan M
Ocul Immunol Inflamm; 2004 Dec; 12(4):297-310. PubMed ID: 15621869
[TBL] [Abstract][Full Text] [Related]
23. Vogt-Koyanagi-Harada syndrome in children.
Rathinam SR; Vijayalakshmi P; Namperumalsamy P; Nozik RA; Cunningham ET
Ocul Immunol Inflamm; 1998 Sep; 6(3):155-61. PubMed ID: 9785605
[TBL] [Abstract][Full Text] [Related]
24. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
[TBL] [Abstract][Full Text] [Related]
25. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
26. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
Kryshtalskyj MT; Roy M
Ocul Immunol Inflamm; 2022 May; 30(4):894-900. PubMed ID: 33621146
[TBL] [Abstract][Full Text] [Related]
27. Clinical profile and treatment outcomes in pediatric uveitis - A series from South India.
Mooss VS; Babu K
Indian J Ophthalmol; 2024 Feb; ():. PubMed ID: 38317316
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa.
Khairallah M; Zaouali S; Messaoud R; Chaabane S; Attia S; Ben Yahia S; Hmidi K
Int Ophthalmol; 2007; 27(2-3):125-30. PubMed ID: 17203358
[TBL] [Abstract][Full Text] [Related]
29. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review.
Islam SM; Tabbara KF
Ophthalmic Epidemiol; 2002 Oct; 9(4):239-49. PubMed ID: 12187422
[TBL] [Abstract][Full Text] [Related]
30. EFFICACY OF COMBINED SYSTEMIC CORTICOSTEROID AND EARLY IMMUNOMODULATORY THERAPY WITHIN THREE MONTHS OF ONSET IN VOGT-KOYANAGI-HARADA DISEASE.
Park HS; Park HY; Lee CS; Lee SC; Lee JH
Retina; 2022 Dec; 42(12):2361-2367. PubMed ID: 36394890
[TBL] [Abstract][Full Text] [Related]
31. Reversal of Peripheral Iris Depigmentation Associated with Vogt-Koyanagi-Harada Disease.
Tobaigy MF; AlBloushi AF; Al-Dhibi HA
Ocul Immunol Inflamm; 2024 May; 32(4):424-428. PubMed ID: 36657743
[TBL] [Abstract][Full Text] [Related]
32. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
33. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
34. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
35. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Accorinti M; Saturno MC; Manni P
Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
[TBL] [Abstract][Full Text] [Related]
36. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 87 cases with Vogt-Koyanagi-Harada disease.
Mondkar SV; Biswas J; Ganesh SK
Jpn J Ophthalmol; 2000; 44(3):296-301. PubMed ID: 10913650
[TBL] [Abstract][Full Text] [Related]
38. Clinical Profile in Genetically Proven Blau Syndrome: A Case Series from South India.
Babu K; Rao AP
Ocul Immunol Inflamm; 2021 Feb; 29(2):250-256. PubMed ID: 32293936
[No Abstract] [Full Text] [Related]
39. An Analysis of the clinical and investigative profile of uveitis in the elderly: First case series from India.
Magesan K; Ahmed A; George AE; Ganesh SK; Biswas J; Dutta Majumder P
Indian J Ophthalmol; 2024 Mar; ():. PubMed ID: 38454869
[TBL] [Abstract][Full Text] [Related]
40. The spectrum of Vogt-Koyanagi-Harada disease in South India.
Murthy SI; Moreker MR; Sangwan VS; Khanna RC; Tejwani S
Int Ophthalmol; 2007; 27(2-3):131-6. PubMed ID: 17318321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
